Ratings HealthEquity, Inc.

Equities

HQY

US42226A1079

Software

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-14 pm EST			5-day change	1st Jan Change
103.61 ^USD	+1.76%		+6.70%	+7.98%

Jan. 14	Deutsche Bank Adjusts HealthEquity Price Target to $108 From $103, Maintains Buy Rating	MT
Dec. 13	Healthequity Insider Sold Shares Worth $2,417,900, According to a Recent SEC Filing	MT

Summary: HealthEquity, Inc.

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
From a short-term investment perspective, the company presents a deteriorated fundamental situation
The company has a good ESG score relative to its sector, according to MSCI.

Highlights: HealthEquity, Inc.

The company's profit outlook over the next few years is a strong asset.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
The group usually releases upbeat results with huge surprise rates.

Weaknesses: HealthEquity, Inc.

With an expected P/E ratio at 92.18 and 57.57 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company's "enterprise value to sales" ratio is among the highest in the world.
The company appears highly valued given the size of its balance sheet.
The company is highly valued given the cash flows generated by its activity.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

Ratings Chart: HealthEquity, Inc.

Source: Surperformance

ESG chart: HealthEquity, Inc.

Source: MSCI

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Fundamentals	Composite Valuation	Composite Momentum	Capi. ($)
	HEALTHEQUITY, INC.				8.82B
	MICROSOFT CORPORATION				3,102B
	PALANTIR TECHNOLOGIES INC.				148B
	CADENCE DESIGN SYSTEMS, INC.				80.22B
	SYNOPSYS, INC.				75.35B
	ATLASSIAN CORPORATION				61.52B
	SEA LIMITED				61.38B
	DASSAULT SYSTÈMES SE				45.47B
	CAMBRICON TECHNOLOGIES CORPORATION LIMITED				40.91B
	ROBLOX CORPORATION				40.27B
	Average				366.37B
	Weighted average by Cap.

See all sector ratings

Investor Rating

Trading Rating

ESG MSCI

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

ESG

Environment

Social

Governance

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes